NWPF

News ArchivesRead News

Nanotech May Tap Into Your Mind

Thursday February 25, 2010

New sensors built using nanotechnology could read and write information directly into the brain.

Discovery News - THE GIST:

The research is likely to provide relief for people with Parkinson's disease or overcoming stroke.
There are a number of hurdles to overcome, such as adverse immune responses and possible faults with the machinery.

Telecommunications researchers in Japan are attempting to create electronic sensors that can not only receive information from the brain, but could manipulate our neural pathways.

While the concept might conjure science-fiction images of half-human, half-machine cyborgs, Dr Keiichi Torimitsu of Nippon Telegraph and Telephone (NTT), says the research is more likely to provide relief for people with Parkinson's disease or overcoming stroke.

Torimitsu presented his team's work on the development of bionic, or bio-mimetic, brain sensors at this week's International Conference on Nanoscience and Nanotechnology (ICONN) in Sydney.

"Establishing connections between the brain and electrical instruments is important for understanding how the brain works and for controlling neural activity," says Torimitsu, who heads NTT's Molecular and Bioscience Group.

"To develop some kind of devices or interfaces with the brain that would make it possible to transmit our information, sending it through the telecommunication pathways to another person or device such as a computer -- that is the goal."

A neural interface would be a significant achievement in the rapidly advancing realm of bionic technology, which includes devices such as the cochlear ear implant.

Torimitsu is working on creating a nano-scaled implant comprising a nano-electrode coated with an artificial membrane that mimics the receptor proteins found on the surface of brain cells, such as glutamate and GABA receptors -involved in increasing and inhibiting brain activity.

Interactions between the receptors and neurotransmitters naturally generate electrical activity. Carefully placed nano-electrodes receive the neurotransmissions providing an instant, accurate electrical reflection of what is occurring, which can be read by an external device.

Torimitsu hopes it would not only monitor activity, but also interact in the connections between neurons known as the synapses.

Ideally, he says, the device would use a biological energy source such as glucose.

"If we could use those proteins on a nano-electrode to generate electrical responses, we could achieve the bio-mimicry of responses."

Torimitsu admits there are a number of hurdles to overcome such as adverse immune responses and possible faults with the machinery. He says at this stage it's unlikely that healthy people would volunteer to have the devices implanted.

But, Torimitsu says it has great medical potential for stroke sufferers and people with Parkinson's disease where brain activity could be controlled.

The Japanese team is working with several researchers in Australia to refine the concept and devise applications for the technology.

Torimitsu has been working with Dr Simon Koblar of the University of Adelaide's Centre for Molecular Genetics of Development, looking at how to apply the technology for the treatment of stroke sufferers.

He is also about to commence working with the University of Wollongong's Intelligent Polymer Research Institute, which works at the forefront of bionics.

Director of the Institute, Professor Gordon Wallace, says one of the goals is to improve the interface with cochlear implant.

He says Torimitsu's work - a meeting of telecommunications technology and biological knowledge -- shows why it makes it a very exciting time to be doing such research.

"People are starting to realize all around the world that there are lots of tools that we can use that we already have at our disposal to make this field progress very quickly," says Wallace.

Recent News

Oct 18 - Fighting Parkinson's disease through dance
Oct 18 - Brain disconnections may contribute to Parkinson's hallucinations
Oct 17 - Scientists Identify Structure of PINK1, Key Parkinson’s-protective Protein
Oct 17 - Diabetes drug cuts Parkinson's risk by 28 percent, study finds
Oct 10 - Advances in Brain Pacemaker Reduces Tremors, Helps Parkinson's Sufferers Live a More Normal Life
Oct 10 - Medical History Could Help Predict Parkinson's Disease Risk Long Before Diagnosis
Oct 3 - Changes in Olfactory Bulb Explain Loss of Smell in Early Stages of Parkinson’s Disease, Study Finds
Oct 3 - Sleep Disturbances May Worsen Motor Symptoms in Parkinson’s Disease, Study Suggests
Sep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show